Tocotrienols regulate bone loss through suppression on osteoclast differentiation and activity

A systematic review

Nur Fathiah Mohd Radzi, Noor Akmal Shareela Ismail, Ekram Alias

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Background: There are accumulating studies reporting that vitamin E in general exhibits bone protective effects. This systematic review, however discusses the effects of a group of vitamin E isomers, tocotrienols in preventing bone loss through osteoclast differentiation and activity suppression. Objective: This review is aimed to discuss the literature reporting the effects of tocotrienols on osteoclasts, the cells specialized for resorbing bone. Results: Out of the total 22 studies from the literature search, only 11 of them were identified as relevant, which comprised of eight animal studies, two in vitro studies and only one combination of both. The in vivo studies indicated that tocotrienols improve the bone health and reduce bone loss via inhibition of osteoclast formation and resorption activity, which could be through regulation of RANKL and OPG expression as seen from their levels in the sera. This is well supported by data from the in vitro studies demonstrating the suppression of osteoclast formation and resorption activity following treatment with tocotrienol isomers. Conclusion: Thus, tocotrienols are suggested to be potential antioxidants for prevention and treatment of bone-related diseases characterized by increased bone loss.

Original languageEnglish
Pages (from-to)1087-1094
Number of pages8
JournalCurrent Drug Targets
Volume19
Issue number9
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Tocotrienols
Osteoclasts
Bone
Bone and Bones
Vitamin E
Isomers
Bone Diseases
Antioxidants
Animals
Health
Serum

Keywords

  • Anti oxidants
  • Bone loss
  • Osteoblasts
  • Osteoclast
  • Osteoclast
  • Tocotrienols

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Tocotrienols regulate bone loss through suppression on osteoclast differentiation and activity : A systematic review. / Radzi, Nur Fathiah Mohd; Ismail, Noor Akmal Shareela; Alias, Ekram.

In: Current Drug Targets, Vol. 19, No. 9, 01.01.2018, p. 1087-1094.

Research output: Contribution to journalReview article

@article{181659fdc64f4e428471d5cca5774f46,
title = "Tocotrienols regulate bone loss through suppression on osteoclast differentiation and activity: A systematic review",
abstract = "Background: There are accumulating studies reporting that vitamin E in general exhibits bone protective effects. This systematic review, however discusses the effects of a group of vitamin E isomers, tocotrienols in preventing bone loss through osteoclast differentiation and activity suppression. Objective: This review is aimed to discuss the literature reporting the effects of tocotrienols on osteoclasts, the cells specialized for resorbing bone. Results: Out of the total 22 studies from the literature search, only 11 of them were identified as relevant, which comprised of eight animal studies, two in vitro studies and only one combination of both. The in vivo studies indicated that tocotrienols improve the bone health and reduce bone loss via inhibition of osteoclast formation and resorption activity, which could be through regulation of RANKL and OPG expression as seen from their levels in the sera. This is well supported by data from the in vitro studies demonstrating the suppression of osteoclast formation and resorption activity following treatment with tocotrienol isomers. Conclusion: Thus, tocotrienols are suggested to be potential antioxidants for prevention and treatment of bone-related diseases characterized by increased bone loss.",
keywords = "Anti oxidants, Bone loss, Osteoblasts, Osteoclast, Osteoclast, Tocotrienols",
author = "Radzi, {Nur Fathiah Mohd} and Ismail, {Noor Akmal Shareela} and Ekram Alias",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1389450118666180516122517",
language = "English",
volume = "19",
pages = "1087--1094",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Tocotrienols regulate bone loss through suppression on osteoclast differentiation and activity

T2 - A systematic review

AU - Radzi, Nur Fathiah Mohd

AU - Ismail, Noor Akmal Shareela

AU - Alias, Ekram

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: There are accumulating studies reporting that vitamin E in general exhibits bone protective effects. This systematic review, however discusses the effects of a group of vitamin E isomers, tocotrienols in preventing bone loss through osteoclast differentiation and activity suppression. Objective: This review is aimed to discuss the literature reporting the effects of tocotrienols on osteoclasts, the cells specialized for resorbing bone. Results: Out of the total 22 studies from the literature search, only 11 of them were identified as relevant, which comprised of eight animal studies, two in vitro studies and only one combination of both. The in vivo studies indicated that tocotrienols improve the bone health and reduce bone loss via inhibition of osteoclast formation and resorption activity, which could be through regulation of RANKL and OPG expression as seen from their levels in the sera. This is well supported by data from the in vitro studies demonstrating the suppression of osteoclast formation and resorption activity following treatment with tocotrienol isomers. Conclusion: Thus, tocotrienols are suggested to be potential antioxidants for prevention and treatment of bone-related diseases characterized by increased bone loss.

AB - Background: There are accumulating studies reporting that vitamin E in general exhibits bone protective effects. This systematic review, however discusses the effects of a group of vitamin E isomers, tocotrienols in preventing bone loss through osteoclast differentiation and activity suppression. Objective: This review is aimed to discuss the literature reporting the effects of tocotrienols on osteoclasts, the cells specialized for resorbing bone. Results: Out of the total 22 studies from the literature search, only 11 of them were identified as relevant, which comprised of eight animal studies, two in vitro studies and only one combination of both. The in vivo studies indicated that tocotrienols improve the bone health and reduce bone loss via inhibition of osteoclast formation and resorption activity, which could be through regulation of RANKL and OPG expression as seen from their levels in the sera. This is well supported by data from the in vitro studies demonstrating the suppression of osteoclast formation and resorption activity following treatment with tocotrienol isomers. Conclusion: Thus, tocotrienols are suggested to be potential antioxidants for prevention and treatment of bone-related diseases characterized by increased bone loss.

KW - Anti oxidants

KW - Bone loss

KW - Osteoblasts

KW - Osteoclast

KW - Osteoclast

KW - Tocotrienols

UR - http://www.scopus.com/inward/record.url?scp=85062795957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062795957&partnerID=8YFLogxK

U2 - 10.2174/1389450118666180516122517

DO - 10.2174/1389450118666180516122517

M3 - Review article

VL - 19

SP - 1087

EP - 1094

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 9

ER -